Form 4: USCB Financial Holdings CEO, Luis de la Aguilera, Receives 125,000 Shares of Restricted Stock
SEC Form 4 Filing
Luis de la Aguilera, President and CEO of USCB Financial Holdings, reports the acquisition of 125,000 shares of restricted stock and updates holdings of existing stock options.
Summary
- On October 28, 2024, Luis de la Aguilera, President and CEO of USCB Financial Holdings, acquired 125,000 shares of Class A Voting Common Stock.
- These shares are restricted stock and will vest at a rate of one-third per year, starting on December 31, 2024.
- Following this transaction, de la Aguilera directly owns 215,874 shares of Class A Voting Common Stock.
- The report also details de la Aguilera's holdings of stock options with various exercise prices and vesting schedules.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The grant of restricted stock is a positive sign of alignment between management and shareholders, but it's a routine filing and doesn't indicate any major strategic shifts.
Positives
- The grant of restricted stock to the CEO aligns his interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the CEO.
- The CEO's existing stock options provide further incentive for company performance.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedules of the restricted stock and stock options.
Industry Context
Executive compensation packages, including stock options and restricted stock, are common in the financial services industry to incentivize performance and retain key personnel.
Comparison to Industry Standards
- Stock grants and options are a typical component of executive compensation in the banking sector.
- Companies like Bank of America, JP Morgan Chase, and Wells Fargo also utilize stock-based compensation to align executive interests with shareholder value.
- The vesting schedules and option terms are generally in line with industry practices for executive compensation.
Stakeholder Impact
- Shareholders may view the stock grant as a positive sign of aligning management's interests with long-term company performance.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 04/01/2017 | Start date for vesting of stock options at $7.50 exercise price. |
| 09/23/2020 | Start date for vesting of stock options at $11.35 exercise price. |
| 09/27/2022 | Start date for vesting of stock options at $12.05 exercise price. |
| 03/08/2024 | Commencement date for vesting of 15,785 restricted shares at a rate of one-third per year. |
| 10/28/2024 | Date of the transaction: acquisition of 125,000 shares of restricted stock. |
| 12/31/2024 | First vesting date for the 125,000 shares of restricted stock. |
| 01/22/2025 | Commencement date for vesting of 12,136 restricted shares at a rate of one-third per year. |
| 04/01/2026 | Expiration date for stock options at $7.50 exercise price. |
| 09/23/2029 | Expiration date for stock options at $11.35 exercise price. |
| 09/27/2031 | Expiration date for stock options at $12.05 exercise price. |
| 10/30/2024 | Date of the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.